Rezolute (RZLT) Debt Ratio (2011 - 2022)

Rezolute (RZLT) posted Debt Ratio of 0.21 for Q1 2022, up 20.79% sequentially from 0.17 in Q4 2021.

Rezolute (RZLT) Debt Ratio (2011 - 2022) Analysis & Trends

Rezolute has reported Debt Ratio for 7 years, with the latest figure at 0.21 in Q1 2022.

Quarterly Debt Ratio changed N/A year-over-year to 0.21 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was 0.21 (changed N/A YoY) and the FY2021 annual result came in at 0.33, changed N/A from the prior year.
Debt Ratio climbed to 0.21 in Q1 2022 per RZLT's latest filing, from 0.17 in the prior quarter.
Over five years, Debt Ratio peaked at 13.48 in Q4 2018 and troughed at 0.17 in Q4 2021.
A 3-year average of 2.47 and a median of 0.32 in 2018 frame the typical range for Debt Ratio.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.05
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.12
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.47
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.26
10	Rezolute	442.94 Mn	442.94 Mn	-	-

Download Data